GLP-1-based therapy for obesity - Lasker Foundation
The 2024 Lasker~DeBakey Clinical Medical Research Award honors three scientists for their discovery and development of GLP-1-based drugs that have revolutionized the treatment of obesity.
Research Leading to Ozempic Honored by 2024 Lasker Awards
Sep 19, 2024 · This year’s Lasker-DeBakey Clinical Medical Research Award went to three scientists for their work on GLP-1, the hormone that led to drugs like Wegovy (the same compound is the basis for...
Harvard Medical School Researcher Wins 2024 Lasker Award for …
Sep 19, 2024 · Harvard Medical School researcher Joel Habener has won the 2024 Lasker~DeBakey Clinical Medical Research Award for his discovery of glucagon-like peptide-1 (GLP-1), a molecule that has become the basis for therapies which have transformed the treatment of obesity.
HMS Professor Wins Prestigious Lasker-DeBakey Award for Work on GLP-1
Sep 25, 2024 · Harvard Medical School professor Joel F. Habener won the 2024 Lasker-DeBakey Clinical Medical Research Award for his work on the glucagon-like peptide-1, the hormone targeted by diabetes drugs...
Obesity-drug pioneers win prestigious Lasker Award for medical
Sep 19, 2024 · Joel Habener, Svetlana Mojsov and Lotte Bjerre Knudsen each contributed to the creation of the popular anti-obesity drugs, which mimic a hormone called glucagon-like peptide 1 (GLP-1),...
GLP-1 for Treating Obesity: 2024 Lasker-DeBakey Clinical Medical ...
Sep 19, 2024 · The 2024 Lasker-DeBakey Clinical Medical Research Award has been presented to Joel Habener, MD, Svetlana Mojsov, PhD, and Lotte Bjerre Knudsen, DMSc, for the discovery of glucagon-like peptide-1 for the treatment of patients with obesity.
Long-overlooked scientist shares Lasker Award with other GLP-1 …
Sep 19, 2024 · GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, addiction, and even Alzheimer’s. Now, three scientists who played key roles in...
Discovery of GLP-1–Based Drugs for the Treatment of Obesity
Sep 19, 2024 · The 2024 Lasker–DeBakey Clinical Medical Research Award recognizes Drs. Habener, Mojsov, and Knudsen, who developed GLP-1 medicines that have revolutionized the treatment of obesity.
Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker …
Sep 19, 2024 · The Lasker Foundation has awarded the 2024 Lasker~DeBakey Clinical Medical Research Award to Joel Habener (Massachusetts General Hospital), Svetlana Mojsov (Rockefeller University), and Lotte Bjerre Knudsen (Novo Nordisk) for their pioneering work on glucagon-like peptide 1 (GLP-1) receptor agonists and their applications to obesity.
Joel Habener receives 2024 Lasker Award - Harvard Medical School
Sep 19, 2024 · Joel is being honored for his discovery of glucagon-like peptide-1 (GLP-1), a molecule that became the basis for GLP-1 therapies that have revolutionized the treatment of type 2 diabetes and obesity.